Whitehawk Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $37.6M | $28.7M | $62.9M | $39.0M | $149.0M | $4.5M | $38.5M | $62.6M |
| Accounts Receivable | $0 | $5.9M | $5.5M | $1.9M | $0 | $14.1M | — | — |
| Inventory | $0 | $5.3M | $6.4M | $1.9M | $0 | — | — | — |
| Total Current Assets | $149.0M | $61.3M | $124.6M | $180.0M | $151.3M | $18.7M | $39.6M | $64.0M |
| Property, Plant & Equipment | $3.0K | $6.8M | $4.8M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | $0 | $3.8M | $0 | — | — |
| Total Assets | $150.8M | $70.3M | $132.4M | $184.2M | $157.9M | $18.8M | $39.9M | $64.1M |
| Liabilities | ||||||||
| Accounts Payable | $917.0K | $2.2M | $5.9M | $3.5M | $6.4M | $2.4M | $439.8K | $595.7K |
| Total Current Liabilities | $14.5M | $17.1M | $26.4M | $18.8M | $15.3M | $30.1M | $3.3M | $5.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $14.5M | $17.8M | $27.2M | $25.9M | $21.5M | $31.3M | $3.4M | $5.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-353.3M | $-332.7M | $-269.0M | $-203.2M | $-142.7M | $-32.6M | $-142.2M | $-119.0M |
| Total Stockholders' Equity | $136.3M | $52.5M | $105.2M | $158.4M | $136.4M | $-12.4M | $-9.1M | $58.7M |